Genetic and epigenetic architecture of mass spectrometry-derived lipids in blood and their role in lifetime Major Depressive Disorder
- 1Institute of Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, UK
Abstract
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder that remains challenging to treat effectively. Difficulty predicting who will develop the disorder and which individuals will respond to treatment is most likely due to our limited mechanistic understanding and the lack of reliable biomarkers. The current literature suggests that lipid profiles differ in MDD; however, most studies do not integrate other omics layers to elucidate their potential causal relationship at the molecular level. Using phenotypic, genetic, epigenetic and mass-spectrometry lipid data from a Scottish-based cohort of approximately 1,000 participants, we examined associations with individual lipid species. We identified 77 common genetic variant associations ({beta} range = -0.46 to 0.69, p < 3.1x10-10) and 82 genome-wide DNA methylation associations ({beta} range = -1.88 to 1.39, p < 2.2x10-10). We identified 23 lipid species associated with lifetime MDD ({beta} range = - 0.23 to 0.2, p < 0.05), including lipid classes such as lysophosphatidylcholine (LPC), diacylglycerol (DG) and phosphatidylcholine (PC). Our integration analysis showed that genetic variants and DNA methylation at sites annotated to the FADS gene cluster were linked with lipid species that were also associated with lifetime MDD status, including LPC(14:1) ({beta} = 0.15, p = 0.03) and PC(19:0)/(20:4) ({beta} = -0.14, p < 0.05). Our findings provide further support for the role of the FADS gene cluster in lipid metabolism and its association with MDD, while introducing DNA methylation as an additional molecular layer supporting this link.
Related
- Epigenetic and Immunometabolic Signatures of Suicidal Behavior in Major Depressive Disorder
- Transdiagnostic metabolic architecture across major depressive disorder and schizophrenia: a NIMETOX systems-biology approach
- Pupil size-resting state network coupling in major depressive disorder: a longitudinal iTBS study
- Biologically informed network-regularized sparse consensus clustering (BioNet-SPACC) identifies a continuous plasma proteomic axis in major depressive disorder
- Sex differences in the association between body mass index and recent suicide attempts in treatment-naïve young adults with major depressive disorder
BibTeX
@misc{smith2026genetic,
title = {{Genetic and epigenetic architecture of mass spectrometry-derived lipids in blood and their role in lifetime Major Depressive Disorder}},
author = {H. M. Smith and A. Richmond and M. J. Adams and A. Wretlind and R. E. Marioni and C. Legido-Quigley and A. M. McIntosh},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.02.26362049},
url = {https://www.medrxiv.org/content/10.64898/2026.09.02.26362049v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Genetic and epigenetic architecture of mass spectrometry-derived lipids in blood and their role in lifetime Major Depressive Disorder
AU - H. M. Smith
AU - A. Richmond
AU - M. J. Adams
AU - A. Wretlind
AU - R. E. Marioni
AU - C. Legido-Quigley
AU - A. M. McIntosh
PY - 2026
DA - 2026/09/02
PB - medRxiv
DO - 10.64898/2026.09.02.26362049
UR - https://www.medrxiv.org/content/10.64898/2026.09.02.26362049v1
AB - Major depressive disorder (MDD) is a highly prevalent psychiatric disorder that remains challenging to treat effectively. Difficulty predicting who will develop the disorder and which individuals will respond to treatment is most likely due to our limited mechanistic understanding and the lack of reliable biomarkers. The current literature suggests that lipid profiles differ in MDD; however, most studies do not integrate other omics layers to elucidate their potential causal relationship at the molecular level. Using phenotypic, genetic, epigenetic and mass-spectrometry lipid data from a Scottish-based cohort of approximately 1,000 participants, we examined associations with individual lipid species. We identified 77 common genetic variant associations ({beta} range = -0.46 to 0.69, p < 3.1x10-10) and 82 genome-wide DNA methylation associations ({beta} range = -1.88 to 1.39, p < 2.2x10-10). We identified 23 lipid species associated with lifetime MDD ({beta} range = - 0.23 to 0.2, p < 0.05), including lipid classes such as lysophosphatidylcholine (LPC), diacylglycerol (DG) and phosphatidylcholine (PC). Our integration analysis showed that genetic variants and DNA methylation at sites annotated to the FADS gene cluster were linked with lipid species that were also associated with lifetime MDD status, including LPC(14:1) ({beta} = 0.15, p = 0.03) and PC(19:0)/(20:4) ({beta} = -0.14, p < 0.05). Our findings provide further support for the role of the FADS gene cluster in lipid metabolism and its association with MDD, while introducing DNA methylation as an additional molecular layer supporting this link.
ER -